North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,328 Jan 1 – Oct 27, 2026
- Disclosed funding
- $260.5B 1931 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| VA Builds emotional intelligence infrastructure for voice AI | $5M | Seed | AI | United States | Investors | |
| OO Onyx OddsCompany profile Social sports prediction platform using exchange-traded instruments and CFTC-regulated prediction markets Social sports prediction platform using exchange-traded instruments and CFTC-regulated prediction markets | $20M | Series A | Fintech | United States | Investors | |
| FF Float FinancialCompany profile Provides an intelligent financial operating system for Canadian businesses covering cards, payments, accounts, and expense management Provides an intelligent financial operating system for Canadian businesses covering cards, payments, accounts, and expense management | CA$85M | Series CSeries C+ | Fintech | Canada | Investors | |
| x Transforms fragmented medical records into decision-ready data | $46M | Series B | Healthtech | United States | Investors | |
| KT Kotoba TechnologiesCompany profile Develops real-time speech models optimized for East Asian languages for agents, devices, and translation Develops real-time speech models optimized for East Asian languages for agents, devices, and translation | $10M | Seed+Seed | AI | United States | Investors | |
| AH Assort HealthCompany profile Provides AI-powered patient journey platform for healthcare organizations Provides AI-powered patient journey platform for healthcare organizations | $120M | Series CSeries C+ | Healthtech | United States | Investors | |
| OB Ollin BiosciencesCompany profile Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD | $330M | Series B | Biotech | United States | Investors | |
| AD ARCYN DefenseCompany profile Develops kinetic energy system to counter unmanned aerial systems and other airborne threats Develops kinetic energy system to counter unmanned aerial systems and other airborne threats | Undisclosed | Seed+Seed | Defense tech | United States | Investors Undisclosed | |
| P PlatformrCompany profile AI CloudOps platform automating AWS environment setup, security, compliance, and cost monitoring for MSPs and SIs AI CloudOps platform automating AWS environment setup, security, compliance, and cost monitoring for MSPs and SIs | $10M | Undisclosed | AI | United States | Investors | |
| AN Anodyne NanotechCompany profile Develops transdermal microneedle patches delivering GLP-1 and biologic therapeutics without injections Develops transdermal microneedle patches delivering GLP-1 and biologic therapeutics without injections | $12.6M | Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
135rounds3led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
100rounds20led - 3General Catalyst
Hyperbolic, Re:Build, Provision Labs
74rounds8led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
59rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.